Jonathan Serody, MD (IMAGE) UNC Lineberger Comprehensive Cancer Center Caption “We hope that these study results will lead to a clinical trial of chemotherapy with or without immunotherapy. We also hope to identify robust biomarkers of response to immunotherapy that can be incorporated into future study designs,” said Jonathan Serody, MD. Credit UNC Lineberger Comprehensive Cancer Center Usage Restrictions None License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.